Table 5.
Comparing the inflammatory markers in study groups before and after intervention.
| The Study Groups | MMD | p-Value ** | |||
|---|---|---|---|---|---|
| Placebo (n = 37) | Vitamin D (n = 34) | ||||
| IL−6 (ng/L) | Before | 129.40 ± 49.60 | 118.29 ± 40.19 | −10.44 | 0.083 |
| After | 133.64 ± 63.04 | 112.30 ± 32.75 | |||
| PC | 4.22 | −3.34 | |||
| p-value * | 0.425 | 0.008 | |||
| IL−10 (ng/L) | Before | 111.11 ± 26.84 | 118.85 ± 26.83 | 6.56 | 0.001 |
| After | 109.46 ± 31.78 | 124.22 ± 26.62 | |||
| PC | −2.22 | 4.75 | |||
| p-value * | 0.332 | <0.001 | |||
| TNFR−2 (ng/L) | Before | 18.37 ± 1.33 | 19.36 ± 5.21 | −1.64 | 0.019 |
| After | 16.78 ± 1.63 | 15.44 ± 4.07 | |||
| PC | −8.01 | −17.38 | |||
| p-value * | <0.001 | <0.001 | |||
* p-value was reported based on Paired sample t test. ** p-value was reported based on ANCOVA after adjustment of baseline values. MMD: Marginal Mean Difference; PC: Percent Change; IL-6: Interleukin 6; IL-10: Interleukin 10; TNF-α: Tumor Necrosis Factor α.